{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:57:15Z","timestamp":1793746635543,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to assess the impact of a prolonged carbapenem use-focused antimicrobial stewardship program (ASP) on antimicrobial consumption and clinical outcomes and to analyze factors affecting adherence to interventions. Patients prescribed carbapenems for\u2009\u2265\u20092\u00a0weeks received intervention. Interrupted time-series analysis was performed to compare antimicrobial consumption before and after intervention. Factors associated with non-adherence to intervention were investigated. Of 273 patients who were eligible for intervention, discontinuation or de-escalation was recommended in 256 (94.1%) and intervention was accepted in 136 (53.1%) patients. Before intervention, carbapenem consumption significantly increased to 1.14\u00a0days of therapy (DOT)\/1000 patient days (PD)\/month (<jats:italic>P<\/jats:italic>\u2009=\u20090.018). However, it significantly declined by \u2212\u20092.01 DOT\/1000 PD\/month without an increase in other antibiotic consumption (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Factors affecting non-adherence to intervention were younger age (odds ratio [OR]\u2009=\u20090.98; 95% confidence interval [CI] 0.96\u20131.00), solid organ malignancy (OR\u2009=\u20092.53, 95% CI 1.16\u20135.50), and pneumonia (OR\u2009=\u20092.59, 95% CI 1.08\u20136.17). However, ASP intervention was not associated with clinical outcomes such as length of hospital stay or mortality. Prolonged carbapenem prescription-focused ASP significantly reduced carbapenem consumption without adverse outcomes. Non-adherence to interventions was attributed more to prescriber-related factors, such as attitude, than patient-related factors including clinical severity.<\/jats:p>","DOI":"10.1038\/s41598-023-41710-4","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:46:42Z","timestamp":1693831602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study"],"prefix":"10.1038","volume":"13","author":[{"given":"Jin Sae","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Jin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hwa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Hwa","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yeon","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"41710_CR1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam, T. F. et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin. Infect. Dis. 62, e51\u2013e77 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"41710_CR2","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1016\/j.ajic.2014.04.023","volume":"42","author":"AL Pakyz","year":"2014","unstructured":"Pakyz, A. L. et al. Facilitators and barriers to implementing antimicrobial stewardship strategies: Results from a qualitative study. Am. J. Infect. Control 42, S257\u2013S263 (2014).","journal-title":"Am. J. Infect. Control"},{"key":"41710_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1017\/ice.2020.1234","volume":"41","author":"SY Park","year":"2020","unstructured":"Park, S. Y. et al. Human resources required for antimicrobial stewardship activities for hospitalized patients in Korea. Infect. Control Hosp. Epidemiol. 41, 1429\u20131435 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"41710_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.cmi.2018.07.005","volume":"24","author":"J ten Oever","year":"2018","unstructured":"ten Oever, J. et al. Human resources required for antimicrobial stewardship teams: A Dutch consensus report. Clin. Microbiol. Infect. 24, 1273\u20131279 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"41710_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri, S. S. et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect. Dis. 21, 241\u2013251 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"41710_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor, C. & Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 5, 229\u2013241 (2014).","journal-title":"Ther. Adv. Drug Saf."},{"key":"41710_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12879-017-2229-8","volume":"17","author":"J Katchanov","year":"2017","unstructured":"Katchanov, J. et al. Risk factors for excessively prolonged meropenem use in the intensive care setting: A case-control study. BMC Infect. Dis. 17, 131 (2017).","journal-title":"BMC Infect. Dis."},{"key":"41710_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1473-3099(18)30792-8","volume":"19","author":"AJ Stewardson","year":"2019","unstructured":"Stewardson, A. J. et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): A multinational prospective cohort study. Lancet Infect. Dis. 19, 601\u2013610 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"41710_CR9","doi-asserted-by":"publisher","first-page":"ofy150","DOI":"10.1093\/ofid\/ofy150","volume":"5","author":"A Martin","year":"2018","unstructured":"Martin, A., Fahrbach, K., Zhao, Q. & Lodise, T. Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to Enterobacteriaceae: results of a systematic literature review and meta-analysis. Open Forum Infect. Dis. 5, ofy150 (2018).","journal-title":"Open Forum Infect. Dis."},{"key":"41710_CR10","doi-asserted-by":"publisher","first-page":"e00736","DOI":"10.1128\/AAC.00736-17","volume":"61","author":"VXF Seah","year":"2017","unstructured":"Seah, V. X. F. et al. Impact of a carbapenem antimicrobial stewardship program on patient outcomes. Antimicrob. Agents Chemother. 61, e00736-e817 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41710_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2020.03.017","volume":"78","author":"A Faraone","year":"2020","unstructured":"Faraone, A. et al. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program. Eur. J. Intern. Med. 78, 50\u201357 (2020).","journal-title":"Eur. J. Intern. Med."},{"key":"41710_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/antibiotics10010015","volume":"10","author":"JF Garc\u00eda-Rodr\u00edguez","year":"2020","unstructured":"Garc\u00eda-Rodr\u00edguez, J. F. et al. Long-term carbapenems antimicrobial stewardship program. Antibiotics 10, 15 (2020).","journal-title":"Antibiotics"},{"key":"41710_CR13","doi-asserted-by":"publisher","first-page":"ofz389","DOI":"10.1093\/ofid\/ofz389","volume":"6","author":"T Akazawa","year":"2019","unstructured":"Akazawa, T. et al. Eight-year experience of antimicrobial stewardship program and the trend of carbapenem use at a tertiary acute-care hospital in Japan\u2014the impact of postprescription review and feedback. Open Forum Infect. Dis. 6, ofz389 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"41710_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1017\/ice.2018.85","volume":"39","author":"LL Bio","year":"2018","unstructured":"Bio, L. L., Kruger, J. F., Lee, B. P., Wood, M. S. & Schwenk, H. T. Predictors of antimicrobial stewardship program recommendation disagreement. Infect. Control Hosp. Epidemiol. 39, 806\u2013813 (2018).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"41710_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.cmi.2020.07.048","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford, B. J., Nisenbaum, R., Brown, K. A., Chan, A. & Downing, M. Antibiotics: Easier to start than to stop? Predictors of antimicrobial stewardship recommendation acceptance. Clin. Microbiol. Infect. 26, 1638\u20131643 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"41710_CR16","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal, J. L., Cummins, S. & Gasparrini, A. Interrupted time series regression for the evaluation of public health interventions: A tutorial. Int. J. Epidemiol. 46, 348\u2013355 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"41710_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/ije\/20.3.808","volume":"20","author":"U Helfenstein","year":"1991","unstructured":"Helfenstein, U. The use of transfer function models, intervention analysis and related time series methods in epidemiology. Int. J. Epidemiol. 20, 808\u2013815 (1991).","journal-title":"Int. J. Epidemiol."},{"key":"41710_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","volume":"8","author":"D Nathwani","year":"2019","unstructured":"Nathwani, D. et al. Value of hospital antimicrobial stewardship programs [ASPs]: A systematic review. Antimicrob. Resist. Infect. Control 8, 35 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"41710_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/jac\/dkx492","volume":"73","author":"CF Lee","year":"2018","unstructured":"Lee, C. F. et al. Impact of antibiotic stewardship programmes in Asia: A systematic review and meta-analysis. J. Antimicrob. Chemother. 73, 844\u2013851 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"41710_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11908-018-0615-z","volume":"20","author":"KC Claeys","year":"2018","unstructured":"Claeys, K. C., Hopkins, T. L., Vega, A. D. & Heil, E. L. Fluoroquinolone restriction as an effective antimicrobial stewardship intervention. Curr. Infect. Dis. Rep. 20, 7 (2018).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"41710_CR21","doi-asserted-by":"publisher","first-page":"12210","DOI":"10.1038\/s41598-018-30673-6","volume":"8","author":"YA Kim","year":"2018","unstructured":"Kim, Y. A., Park, Y. S., Youk, T., Lee, H. & Lee, K. Changes in antimicrobial usage patterns in Korea: 12-year analysis based on database of the national health insurance service-national sample cohort. Sci. Rep. 8, 12210 (2018).","journal-title":"Sci. Rep."},{"key":"41710_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2013.08.001","volume":"2","author":"G Levy Hara","year":"2014","unstructured":"Levy Hara, G. Antimicrobial stewardship in hospitals: Does it work and can we do it?. J. Glob. Antimicrob. Resist. 2, 1\u20136 (2014).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"41710_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/jac\/dku497","volume":"70","author":"P Howard","year":"2015","unstructured":"Howard, P. et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J. Antimicrob. Chemother. 70, 1245\u20131255 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"41710_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhin.2019.09.003","volume":"104","author":"B Kim","year":"2020","unstructured":"Kim, B. et al. Current status of antimicrobial stewardship programmes in Korean hospitals: Results of a 2018 nationwide survey. J. Hosp. Infect. 104, 172\u2013180 (2020).","journal-title":"J. Hosp. Infect."},{"key":"41710_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero, J. et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 40, 32\u201340 (2014).","journal-title":"Intensive Care Med."},{"key":"41710_CR26","first-page":"S194","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone, M. et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 40, S194\u2013S195 (2014).","journal-title":"Intensive Care Med."},{"key":"41710_CR27","first-page":"CD007934","volume":"2013","author":"BNG Silva","year":"2013","unstructured":"Silva, B. N. G., Andriolo, R. B., Atallah, \u00c1. N. & Salom\u00e3o, R. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst. Rev. 2013, CD007934 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"41710_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archinternmed.2011.29","volume":"171","author":"TC Jenkins","year":"2011","unstructured":"Jenkins, T. C. et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch. Intern. Med. 171, 1072\u20131079 (2011).","journal-title":"Arch. Intern. Med."},{"key":"41710_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/cid\/cis242","volume":"54","author":"E Avdic","year":"2012","unstructured":"Avdic, E. et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin. Infect. Dis. 54, 1581\u20131587 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"41710_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcrc.2019.06.026","volume":"54","author":"BS Kwon","year":"2019","unstructured":"Kwon, B. S. et al. Safety of antimicrobial de-escalation for culture-negative severe pneumonia. J. Crit. Care 54, 14\u201319 (2019).","journal-title":"J. Crit. Care"},{"key":"41710_CR31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00277-020-04132-0","volume":"99","author":"L Rearigh","year":"2020","unstructured":"Rearigh, L., Stohs, E., Freifeld, A. & Zimmer, A. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia. Ann. Hematol. 99, 1917\u20131924 (2020).","journal-title":"Ann. Hematol."},{"key":"41710_CR32","doi-asserted-by":"publisher","first-page":"ofab624","DOI":"10.1093\/ofid\/ofab624","volume":"9","author":"A Verlinden","year":"2022","unstructured":"Verlinden, A. et al. Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: A single-center experience. Open Forum Infect. Dis. 9, ofab624 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"41710_CR33","doi-asserted-by":"publisher","first-page":"ofaa007","DOI":"10.1093\/ofid\/ofaa007","volume":"7","author":"VM Vaughn","year":"2020","unstructured":"Vaughn, V. M. et al. A deeper dive into antibiotic stewardship needs: A multihospital survey. Open Forum Infect. Dis. 7, ofaa007 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"41710_CR34","unstructured":"Centers for Disease Control and Prevention (CDC). Core elements of hospital antibiotic stewardship programs. https:\/\/www.cdc.gov\/antibiotic-use\/healthcare\/pdfs\/hospital-core-elements-H.pdf (2019)."},{"key":"41710_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1086\/664771","volume":"33","author":"SE Cosgrove","year":"2015","unstructured":"Cosgrove, S. E. et al. Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: A multicenter intervention. Infect. Control Hosp. Epidemiol. 33, 374\u2013380 (2015).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"41710_CR36","doi-asserted-by":"publisher","first-page":"ofaa298","DOI":"10.1093\/ofid\/ofaa298","volume":"7","author":"A Takamatsu","year":"2020","unstructured":"Takamatsu, A. et al. Barriers to adherence to antimicrobial stewardship postprescription review and feedback for broad-spectrum antimicrobial agents: A nested case-control study. Open Forum Infect. Dis. 7, ofaa298 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"41710_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jgar.2020.04.006","volume":"22","author":"LE Wee","year":"2020","unstructured":"Wee, L. E. et al. Who listens and who doesn\u2019t? Factors associated with adherence to antibiotic stewardship intervention in a Singaporean tertiary hospital. J. Glob. Antimicrob. Resist. 22, 391\u2013397 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"41710_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajic.2017.02.030","volume":"45","author":"K Buehrle","year":"2017","unstructured":"Buehrle, K., Pisano, J., Han, Z. & Pettit, N. N. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. Am. J. Infect. Control 45, 713\u2013716 (2017).","journal-title":"Am. J. Infect. Control"},{"key":"41710_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1197\/jamia.M1749","volume":"13","author":"AD Harris","year":"2006","unstructured":"Harris, A. D. et al. The use and interpretation of quasi-experimental studies in medical informatics. J. Am. Med. Inform. Assoc. 13, 16\u201323 (2006).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"41710_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1086\/420936","volume":"38","author":"AD Harris","year":"2004","unstructured":"Harris, A. D. et al. The use and interpretation of quasi-experimental studies in infectious diseases. Clin. Infect. Dis. 38, 1586\u20131591 (2004).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41710-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:12:37Z","timestamp":1700385157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41710-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41710-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14501"}}